Efficacy and Safety of Biosimilar QL1207 vs. the Reference Aflibercept for Patients with Neovascular Age-Related Macular Degeneration: A Randomized Phase 3 Trial.
Saved in:
| Title: | Efficacy and Safety of Biosimilar QL1207 vs. the Reference Aflibercept for Patients with Neovascular Age-Related Macular Degeneration: A Randomized Phase 3 Trial. |
|---|---|
| Authors: | Li, Bing1 (AUTHOR), Fan, Ke2 (AUTHOR), Zhang, Tonghe3 (AUTHOR), Wu, Zhifeng4 (AUTHOR), Zeng, Siming5 (AUTHOR), Zhao, Mingwei6 (AUTHOR), Ren, Qian7 (AUTHOR), Zheng, Dongping8 (AUTHOR), Wang, Lifei9 (AUTHOR), Liu, Xiaoling10 (AUTHOR), Han, Mei11 (AUTHOR), Song, Yanping12 (AUTHOR), Ye, Jian13 (AUTHOR), Pei, Cheng14 (AUTHOR), Yi, Jinglin15 (AUTHOR), Wang, Xian16 (AUTHOR), Peng, Hui17 (AUTHOR), Zhang, Hong18 (AUTHOR), Zhou, Zhanyu19 (AUTHOR), Liang, Xiaoling20 (AUTHOR) |
| Source: | Ophthalmology & Therapy. Jan2024, Vol. 13 Issue 1, p353-366. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 174685384 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and Safety of Biosimilar QL1207 vs. the Reference Aflibercept for Patients with Neovascular Age-Related Macular Degeneration: A Randomized Phase 3 Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Li%2C+Bing%22">Li, Bing</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fan%2C+Ke%22">Fan, Ke</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Tonghe%22">Zhang, Tonghe</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Zhifeng%22">Wu, Zhifeng</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zeng%2C+Siming%22">Zeng, Siming</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhao%2C+Mingwei%22">Zhao, Mingwei</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ren%2C+Qian%22">Ren, Qian</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zheng%2C+Dongping%22">Zheng, Dongping</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Lifei%22">Wang, Lifei</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Xiaoling%22">Liu, Xiaoling</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Han%2C+Mei%22">Han, Mei</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Song%2C+Yanping%22">Song, Yanping</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ye%2C+Jian%22">Ye, Jian</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pei%2C+Cheng%22">Pei, Cheng</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yi%2C+Jinglin%22">Yi, Jinglin</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Xian%22">Wang, Xian</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Peng%2C+Hui%22">Peng, Hui</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Hong%22">Zhang, Hong</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Zhanyu%22">Zhou, Zhanyu</searchLink><relatesTo>19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liang%2C+Xiaoling%22">Liang, Xiaoling</searchLink><relatesTo>20</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Ophthalmology+%26+Therapy%22">Ophthalmology & Therapy</searchLink>. Jan2024, Vol. 13 Issue 1, p353-366. 14p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=174685384 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40123-023-00836-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 14 StartPage: 353 Titles: – TitleFull: Efficacy and Safety of Biosimilar QL1207 vs. the Reference Aflibercept for Patients with Neovascular Age-Related Macular Degeneration: A Randomized Phase 3 Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Li, Bing – PersonEntity: Name: NameFull: Fan, Ke – PersonEntity: Name: NameFull: Zhang, Tonghe – PersonEntity: Name: NameFull: Wu, Zhifeng – PersonEntity: Name: NameFull: Zeng, Siming – PersonEntity: Name: NameFull: Zhao, Mingwei – PersonEntity: Name: NameFull: Ren, Qian – PersonEntity: Name: NameFull: Zheng, Dongping – PersonEntity: Name: NameFull: Wang, Lifei – PersonEntity: Name: NameFull: Liu, Xiaoling – PersonEntity: Name: NameFull: Han, Mei – PersonEntity: Name: NameFull: Song, Yanping – PersonEntity: Name: NameFull: Ye, Jian – PersonEntity: Name: NameFull: Pei, Cheng – PersonEntity: Name: NameFull: Yi, Jinglin – PersonEntity: Name: NameFull: Wang, Xian – PersonEntity: Name: NameFull: Peng, Hui – PersonEntity: Name: NameFull: Zhang, Hong – PersonEntity: Name: NameFull: Zhou, Zhanyu – PersonEntity: Name: NameFull: Liang, Xiaoling IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: Jan2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 21938245 Numbering: – Type: volume Value: 13 – Type: issue Value: 1 Titles: – TitleFull: Ophthalmology & Therapy Type: main |
| ResultId | 1 |